| Members |
targetComponentId |
| Driving instructor (& [private]) |
Private driving instructor |
| Driving instructor (& [private]) |
Private driving instructor |
| Driving licence |
Has driver's license (finding) |
| Driving licence: [refused] or [loss of] |
Driving license refused (finding) |
| Driving licence: [refused] or [loss of] |
Loss of driving licence |
| Driving licence: [refused] or [loss of] |
Driving license refused (finding) |
| Driving licence: [refused] or [loss of] |
Loss of driving licence |
| Driving license |
Has driver's license (finding) |
| Driving/traffic examiner |
Driving examiner |
| Driving/traffic examiner |
Traffic examiner |
| Dropped beat |
QRS complex dropped |
| Dropped beat |
Premature beats |
| Dropped beats - heart |
Premature beats |
| Dropped beats - heart |
QRS complex dropped |
| Drops dose form |
Oral solution |
| Droxidopa 100mg capsule |
Droxidopa 100 mg oral capsule |
| Droxidopa 200mg capsule |
Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug) |
| Droxidopa 300mg capsule |
Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug) |
| Drug &/or toxic polyneuropathy |
Toxic polyneuropathy |
| Drug AND/OR toxin-induced diarrhea |
Infectious diarrheal disease |
| Drug AND/OR toxin-induced diarrhea |
Diarrhea caused by drug |
| Drug Rx stopped - end of trial |
Drug treatment stopped at end of clinical trial (situation) |
| Drug abuse |
Episode of harmful substance use |
| Drug abuse |
Harmful pattern of substance use (disorder) |
| Drug abuse prevention |
Prevention of harmful pattern of substance use (procedure) |
| Drug abuse prevention assessment |
Assessment of prevention of harmful pattern of substance use (procedure) |
| Drug abuse prevention education |
Substance abuse prevention education |
| Drug abuse prevention management |
Management of prevention of harmful pattern of substance use (procedure) |
| Drug abuse, continuous |
Continuous harmful pattern of substance use |
| Drug addict: [notific to CMO] or [HS2A 1(Rev) to HO] |
Drug addiction notification |
| Drug addict: [notific to CMO] or [HS2A 1(Rev) to HO] |
Drug addiction notification |
| Drug addict: [renotif to CMO] or [renotif-HS2A to HO] |
Drug addiction notification |
| Drug addict: [renotif to CMO] or [renotif-HS2A to HO] |
Drug addiction notification |
| Drug addiction notification (& admin) |
Drug addiction notification |
| Drug addiction notification |
Drug addiction notification |
| Drug allergen |
Substance |
| Drug allergy |
Allergic reaction to drug |
| Drug allergy |
Allergy to drug |
| Drug and heavy metal |
Drug or medicament (substance) |
| Drug and heavy metal |
Heavy metal |
| Drug builder |
Drug excipient |
| Drug dependence: [absinthe] or [other specified] |
Absinthe addiction |
| Drug dosage medication |
Drug dosage education (procedure) |
| Drug dose form |
Basic dose form (basic dose form) |
| Drug dose form |
Pharmaceutical dose form (dose form) |
| Drug emulsion |
Emulsion |
| Drug for the treatment of gout adverse reaction |
Colchicum alkaloid adverse reaction |
| Drug for the treatment of gout adverse reaction |
Uricosuric agent adverse reaction |
| Drug for the treatment of gout adverse reaction |
Colchicine adverse reaction |
| Drug groups primarily affecting the cardiovascular system |
Pharmaceutical / biologic product (product) |
| Drug induced: [agranulocytosis] or [neutropenia] |
Drug-induced neutropenia |
| Drug lotion |
Lotion (basic dose form) |
| Drug lotion, 0,025% |
Lotion (basic dose form) |
| Drug lotion, 0,05% |
Lotion (basic dose form) |
| Drug lotion, 0,1% |
Lotion (basic dose form) |
| Drug lotion, 0,25% |
Lotion (basic dose form) |
| Drug lotion, 0,5% |
Lotion (basic dose form) |
| Drug lotion, 1% |
Lotion (basic dose form) |
| Drug lotion, 2,5% |
Lotion (basic dose form) |
| Drug measurement |
Measurement of substance (procedure) |
| Drug monitoring not required |
Medication monitoring not indicated |
| Drug not taken - pat disbelief |
Drugs not taken/completed |
| Drug or toxin |
Toxin |
| Drug or toxin |
Drug or medicament (substance) |
| Drug overdose |
Overdose |
| Drug overdose of undetermined intent |
Overdose |
| Drug paste |
Paste |
| Drug paste, 0,5% |
Paste |
| Drug photoallergic response |
Photosensitivity caused by drug (disorder) |
| Drug powder |
Powder (basic dose form) |
| Drug powder and solvent |
Powder (basic dose form) |
| Drug prescription |
Prescription of drug |
| Drug prescription |
Medicinal prescription record |
| Drug reaction - anti-inflammatory analgesic |
Non-steroidal anti-inflammatory drug adverse reaction (disorder) |
| Drug reaction - anti-inflammatory analgesic |
Non-steroidal anti-inflammatory drug adverse reaction (disorder) |
| Drug reaction - endocrine NOS |
Adverse reaction to hormone |
| Drug reaction - endocrine NOS |
Adverse reaction to hormone |
| Drug reaction - endocrine drug |
Adverse reaction to hormone |
| Drug reaction - endocrine drug |
Adverse reaction to hormone |
| Drug resistant Streptococcus pneumoniae |
Multiple drug-resistant Streptococcus pneumoniae (organism) |
| Drug resistant Streptococcus pneumoniae |
Penicillin resistant Streptococcus pneumoniae (organism) |
| Drug screen |
Measurement of substance (procedure) |
| Drug screening test |
Measurement of substance (procedure) |
| Drug screening test |
Measurement of substance (procedure) |
| Drug screening test |
Measurement of substance (procedure) |
| Drug solution |
Solution |
| Drug suspension |
Suspension |
| Drug therapy |
Chemotherapy |
| Drug therapy (& intramuscular injection) |
Chemotherapy |
| Drug therapy (& intramuscular injection) |
Drug therapy (procedure) |
| Drug therapy |
Drug therapy (procedure) |
| Drug therapy |
Drug therapy (procedure) |
| Drug therapy |
Chemotherapy |
| Drug therapy stopped (& on medical advice) |
Drug treatment stopped - medical advice |
| Drug therapy stopped (& on medical advice) |
Drug therapy discontinued (situation) |
| Drug therapy stopped (& on medical advice) |
Drug therapy discontinued (situation) |
| Drug therapy stopped (& on medical advice) |
Drug treatment stopped - medical advice |
| Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions |
Drug-induced tubulointerstitial nephritis (disorder) |
| Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions |
Heavy-metal-induced tubulointerstitial nephritis (disorder) |
| Drug-induced contact dermatitis |
Contact dermatitis |
| Drug-induced diffuse interstitial pulmonary fibrosis |
Interstitial pulmonary fibrosis due to inhalation of drug |